Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2003Blood

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMorgan HakkiOregon Health & Science UniversitySRStanley R. RiddellScripps Research InstituteJSJan StorekAlberta Health Services

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hakki et al. (2003) studied this question.

synapsesocial.com/papers/6a7e1108990ff6f3c7e4fbcahttps://doi.org/10.1182/blood-2002-11-3472
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)2001 · 530 citations
  2. 2Risk of Infectious Complications in Patients Taking Glucocorticosteroids1989 · 840 citations
  3. 3Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation2001 · 399 citations
  4. 4Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention1994 · 104 citations
  5. 5Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)1999 · 68 citations